Andlauer Healthcare Gr (AND) - Net Assets
Based on the latest financial reports, Andlauer Healthcare Gr (AND) has net assets worth CA$439.77 Million CAD (≈ $318.12 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$687.97 Million ≈ $497.67 Million USD) and total liabilities (CA$248.20 Million ≈ $179.54 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore Andlauer Healthcare Gr (AND) cash flow conversion to assess how effectively this company generates cash.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$439.77 Million |
| % of Total Assets | 63.92% |
| Annual Growth Rate | 14.42% |
| 5-Year Change | 357.06% |
| 10-Year Change | N/A |
| Growth Volatility | 94.31 |
Andlauer Healthcare Gr - Net Assets Trend (2016–2024)
This chart illustrates how Andlauer Healthcare Gr's net assets have evolved over time, based on quarterly financial data. Explore Andlauer Healthcare Gr (AND) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Net Assets for Andlauer Healthcare Gr (2016–2024)
The table below shows the annual net assets of Andlauer Healthcare Gr from 2016 to 2024. For live valuation and market cap data, see market value of Andlauer Healthcare Gr.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CA$431.13 Million ≈ $311.87 Million |
-8.19% |
| 2023-12-31 | CA$469.57 Million ≈ $339.68 Million |
+6.48% |
| 2022-12-31 | CA$440.99 Million ≈ $319.01 Million |
+25.24% |
| 2021-12-31 | CA$352.12 Million ≈ $254.72 Million |
+273.30% |
| 2020-12-31 | CA$94.33 Million ≈ $68.23 Million |
+53.36% |
| 2019-12-31 | CA$61.51 Million ≈ $44.49 Million |
-63.76% |
| 2018-12-31 | CA$169.73 Million ≈ $122.78 Million |
+1.30% |
| 2017-12-31 | CA$167.54 Million ≈ $121.20 Million |
+14.16% |
| 2016-12-31 | CA$146.76 Million ≈ $106.16 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Andlauer Healthcare Gr's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 20538100000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CA$205.38 Million | 47.64% |
| Other Components | CA$225.75 Million | 52.36% |
| Total Equity | CA$431.13 Million | 100.00% |
Andlauer Healthcare Gr Competitors by Market Cap
The table below lists competitors of Andlauer Healthcare Gr ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jiangsu Jibeier Pharmaceutical Co Ltd
SHG:688566
|
$729.58 Million |
|
SEC Electric Mach Co Ltd
SHG:603988
|
$729.64 Million |
|
Red Violet Inc
NASDAQ:RDVT
|
$729.75 Million |
|
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829
|
$729.76 Million |
|
Akasha Wira International Tbk
JK:ADES
|
$729.33 Million |
|
Barco NV
BR:BAR
|
$729.24 Million |
|
PharmaResources (Shanghai) Co. Ltd. A
SHE:301230
|
$729.20 Million |
|
Gujarat State Fertilizers & Chemicals Limited
NSE:GSFC
|
$729.19 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Andlauer Healthcare Gr's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 469,570,000 to 431,132,000, a change of -38,438,000 (-8.2%).
- Net income of 64,468,000 contributed positively to equity growth.
- Dividend payments of 16,723,000 reduced retained earnings.
- Share repurchases of 106,673,000 reduced equity.
- Other comprehensive income decreased equity by 14,194,000.
- Other factors increased equity by 34,684,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$64.47 Million | +14.95% |
| Dividends Paid | CA$16.72 Million | -3.88% |
| Share Repurchases | CA$106.67 Million | -24.74% |
| Other Comprehensive Income | CA$-14.19 Million | -3.29% |
| Other Changes | CA$34.68 Million | +8.04% |
| Total Change | CA$- | -8.19% |
Book Value vs Market Value Analysis
This analysis compares Andlauer Healthcare Gr's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.00x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 14.53x to 5.00x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | CA$3.78 | CA$54.97 | x |
| 2017-12-31 | CA$4.36 | CA$54.97 | x |
| 2018-12-31 | CA$4.54 | CA$54.97 | x |
| 2019-12-31 | CA$1.63 | CA$54.97 | x |
| 2020-12-31 | CA$2.45 | CA$54.97 | x |
| 2021-12-31 | CA$8.80 | CA$54.97 | x |
| 2022-12-31 | CA$10.33 | CA$54.97 | x |
| 2023-12-31 | CA$11.04 | CA$54.97 | x |
| 2024-12-31 | CA$10.98 | CA$54.97 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Andlauer Healthcare Gr utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.95%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.91%
- • Asset Turnover: 0.93x
- • Equity Multiplier: 1.62x
- Recent ROE (14.95%) is below the historical average (22.71%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 14.02% | 8.56% | 0.87x | 1.88x | CA$5.49 Million |
| 2017 | 13.78% | 8.64% | 0.94x | 1.70x | CA$5.94 Million |
| 2018 | 16.31% | 9.65% | 1.00x | 1.69x | CA$10.34 Million |
| 2019 | 48.41% | 10.27% | 1.36x | 3.46x | CA$23.62 Million |
| 2020 | 39.98% | 12.00% | 1.24x | 2.68x | CA$28.28 Million |
| 2021 | 25.55% | 20.44% | 0.68x | 1.83x | CA$54.74 Million |
| 2022 | 17.30% | 11.76% | 0.91x | 1.62x | CA$32.18 Million |
| 2023 | 14.09% | 10.21% | 0.95x | 1.45x | CA$19.18 Million |
| 2024 | 14.95% | 9.91% | 0.93x | 1.62x | CA$21.35 Million |
Industry Comparison
This section compares Andlauer Healthcare Gr's net assets metrics with peer companies in the Integrated Freight & Logistics industry.
Industry Context
- Industry: Integrated Freight & Logistics
- Average net assets among peers: $66,600,000
- Average return on equity (ROE) among peers: 3.60%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Andlauer Healthcare Gr (AND) | CA$439.77 Million | 14.02% | 0.56x | $729.37 Million |
| Cargojet Inc (CJT) | $66.60 Million | 3.60% | 5.94x | $938.20 Million |
About Andlauer Healthcare Gr
Andlauer Healthcare Group Inc. operates as a supply chain management company providing a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company provides solutions for logistics and distribution, packaging, ground transportation, air freight forwarding, and dedicated and last minute delivery… Read more